Patents by Inventor J. Carr

J. Carr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cascade ordering
    Patent number: 8959300
    Abstract: For handling multiple backup processes, computer-readable program code is described for receiving one or more instructions initiating a plurality of backup processes from a single source storage volume to a plurality of target storage volumes, adding each target storage volume to a cascade of target storage volumes from the source storage volume, the target storage volumes added to the cascade in an order inversely proportional to the copy rate of the respective backup process, and starting each backup process in turn, the backup processes started in an order from the most recent target storage volume added to cascade to the first target storage volume added to cascade.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: February 17, 2015
    Assignee: International Business Machines Corporation
    Inventors: John P. Agombar, Christopher B. Beeken, David J. Carr
  • Phone stand assembly
    Patent number: 8950720
    Abstract: A phone stand assembly provides a stand to support a personal phone in a viewable hands free position. An embodiment of the assembly includes a planar member having a back section, a front section, and a base section extending between the back section and the front section. The front section and back sections are pivotally coupled to the base section. The front section is selectively couplable to the back section when the front section and the back section are pivoted relative to the base section. An opening is positioned in the front section. The opening is configured for receiving a phone therein whereby the phone is supported in an upright position.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: February 10, 2015
    Inventor: Brett J. Carr
  • Cytotoxins comprising modified bouganin toxin for the treatment of cancer
    Publication number: 20150018526
    Abstract: The invention provides modified forms of bouganin protein having biological activity and a reduced propensity to activate human T cells as compared to the non-modified bouganin protein. The invention also provides T-cell epitope peptides of bouganin, and modified T-cell epitope peptides of bouganin which have a reduced propensity to activate human T cells as compared to the non-modified T-cell epitope peptide. The invention also provides cytotoxins having the having a ligand that binds to a cancer cells attached to the modified bouganin proteins. Also provided are methods of inhibiting or destroying mammalian cancer cells using the cytotoxins of the invention and pharmaceutical compositions for treating human cancer.
    Type: Application
    Filed: April 1, 2014
    Publication date: January 15, 2015
    Applicant: Merck Patent GmbH
    Inventors: Matthew BAKER, Francis J. CARR, Koen HELLENDOORN, Jeannick CIZEAU, Glen C. MACDONALD, Joycelyn ENTWISTLE, Denis G. BOSC, Nicholas R. GLOVER
  • Lighting control protocol
    Patent number: 8878644
    Abstract: A digital lighting control network protocol with forward and backward frames, each of the frames including an error check code. A no-acknowledgment (NAK) signal is sent from a receiving node to a transmitting node responsive to the error check code. An interface circuit of the receiving node may include an energy storage section to store at least some energy from the network while receiving digital signals, and an output section to transmit digital signals to the network using the stored energy. The interface circuit may also include a high voltage buffer circuit. The transmitting node may send forward frames to receiving nodes based on device type.
    Type: Grant
    Filed: October 16, 2012
    Date of Patent: November 4, 2014
    Assignee: Leviton Manufacturing Co., Inc.
    Inventors: Robert L. Hick, Edward J. Carr, Richard A. Leinen, Paul S. Maddox
  • NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF
    Publication number: 20140315255
    Abstract: The present invention relates to novel therapeutics with antibacterial activity, processes for their preparation, and pharmaceutical, veterinary and nutritional compositions containing them as active ingredients. The present invention also relates to uses of the novel therapeutics, for example, as medicants or food additives in the treatment of bacterial infections or to aid body mass gain in a subject.
    Type: Application
    Filed: February 13, 2014
    Publication date: October 23, 2014
    Applicant: Albany Molecular Research, Inc.
    Inventors: Grant J. Carr, David D. Manning, Zhicai Yang, Cheng Guo, Jun-Ho Maeng, John RABENSTEIN
  • Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
    Patent number: 8758757
    Abstract: Humanized monoclonal antibodies which bind to IFNAR-1, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the humanized antibodies and therapeutic and diagnostic methods for using the humanized antibodies.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: June 24, 2014
    Assignee: Medarex, L.L.C.
    Inventors: Josephine M. Cardarelli, Tseng-hui Timothy Chen, David King, Christopher R. Bebbington, Sarah Lee Pogue, Francis J. Carr, Stephen Williams
  • Antibacterial compounds, methods of making them, and uses thereof
    Patent number: 8754054
    Abstract: The present invention relates to novel therapeutics with antibacterial activity, processes for their preparation, and pharmaceutical, veterinary and nutritional compositions containing them as active ingredients. The present invention also relates to uses of the novel therapeutics, for example, as medicants or food additives in the treatment of bacterial infections or to aid body mass gain in a subject.
    Type: Grant
    Filed: September 17, 2010
    Date of Patent: June 17, 2014
    Assignee: Albany Molecular Research, Inc.
    Inventors: Grant J. Carr, David D. Manning, Zhicai Yang, Cheng Guo, Jun-Ho Maeng, Peter C. Michels, Matthew W. Chase
  • Cytotoxins comprising modified bouganin toxin for the treatment of cancer
    Patent number: 8716234
    Abstract: The invention provides modified forms of bouganin protein having biological activity and a reduced propensity to activate human T cells as compared to the non-modified bouganin protein. The invention also provides T-cell epitope peptides of bouganin, and modified T-cell epitope peptides of bouganin which have a reduced propensity to activate human T cells as compared to the non-modified T-cell epitope peptide. The invention also provides cytotoxins having the having a ligand that binds to a cancer cells attached to the modified bouganin proteins. Also provided are methods of inhibiting or destroying mammalian cancer cells using the cytotoxins of the invention and pharmaceutical compositions for treating human cancer.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: May 6, 2014
    Assignee: Merck Patent GmbH
    Inventors: Matthew Baker, Francis J. Carr, Koen Hellendoorn, Jeannick Cizeau, Glen Christopher MacDonald, Joycelyn Entwistle, Denis Georges Bosc, Nicholas Ronald Glover
  • Communicating ancillary information associated with a plurality of audio/video programs
    Patent number: 8719887
    Abstract: A system includes a receiver and a communication interface. The receiver is adapted to tune to an audio/video portion over a transport medium. The communication interface is adapted to receive announcement data associated with the tuned audio/video content directed to a first addressable location and to receive a special announcement directed to the first addressable location. The special announcement indicates availability of the announcement data associated with the tuned audio/video program, and the announcement data is associated with the tuned audio/video content and indicates enhancement data is being transmitted. The controller is adapted to redirect the announcement data to a second addressable location other than the first addressable location in response to the special announcement.
    Type: Grant
    Filed: August 19, 2009
    Date of Patent: May 6, 2014
    Assignee: Intel Corporation
    Inventor: Wayne J. Carr
  • MONOCLONAL ANTIBODIES FOR ENHANCING OR INHIBITING INSULIN-LIKE GROWTH FACTOR 1 (IGF-1)
    Publication number: 20140072568
    Abstract: The present invention provides an antibody or antigen-binding fragment thereof that binds ?V?3 integrin, as well as methods of use in the treatment of diseases and disorders.
    Type: Application
    Filed: August 30, 2013
    Publication date: March 13, 2014
    Applicant: The University of North Carolina at Chapel Hill
    Inventors: David Clemmons, Laura Maile, Michael Naso, Francis J. Carr, Timothy D. Jones, Simon William Keen
  • HUMAN ANTI-PD-1, PD-L1, AND PD-L2 ANTIBODIES AND USES THEREFOR
    Publication number: 20130291136
    Abstract: The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity (e.g., persistent infectious diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors) using the novel human anti-PD-1, PD-L1, and PD-L2 antibodies described herein.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 31, 2013
    Inventors: Gordon J. FREEMAN, Rafi AHMED, Timothy D. JONES, Francis J. CARR, James P. GREGSON
  • Grinder bit
    Patent number: 8567872
    Abstract: An apparatus for grinding material includes a grinder bit including a drum and a plurality of grinders, at least a portion of the grinders disposed longitudinally in a first helical pattern along the outer surface of the drum. The apparatus further includes a plurality of cleats, at least a portion of the cleats disposed longitudinally in a second helical pattern along the outer surface of the drum. The second helical pattern is offset from the first helical pattern.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: October 29, 2013
    Assignee: Raytheon Company
    Inventor: Jonathan J. Carr
  • LIGHTING CONTROL PROTOCOL
    Publication number: 20130279553
    Abstract: A digital lighting control network protocol with forward and backward frames, each of the frames including an error check code. A no-acknowledgment (NAK) signal is sent from a receiving node to a transmitting node responsive to the error check code. An interface circuit of the receiving node may include an energy storage section to store at least some energy from the network while receiving digital signals, and an output section to transmit digital signals to the network using the stored energy. The interface circuit may also include a high voltage buffer circuit. The transmitting node may send forward frames to receiving nodes based on device type.
    Type: Application
    Filed: October 16, 2012
    Publication date: October 24, 2013
    Inventors: Robert L. Hick, Edward J. Carr, Richard A. Leinen, Paul S. Maddox
  • MARKETING METHOD FOR ARTIFICIAL TURF AT AIRPORTS
    Publication number: 20130268330
    Abstract: An airport advertising system includes a backing securely installed adjacent to an airport runway or taxiway, a plurality of base fibers secured to the backing, and a plurality of advertisement forming fibers secured to the backing so as to visually define at least a portion of an airport advertisement.
    Type: Application
    Filed: June 6, 2013
    Publication date: October 10, 2013
    Inventor: Patrick J. Carr
  • Anti-PD-L1 antibodies and uses therefor
    Patent number: 8552154
    Abstract: The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity (e.g., persistent infectious diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors) using the novel human anti-PD-1, PD-L1, and PD-L2 antibodies described herein.
    Type: Grant
    Filed: September 25, 2009
    Date of Patent: October 8, 2013
    Assignees: Emory University, Dana-Farber Cancer Institute, Inc.
    Inventors: Gordon J. Freeman, Rafi Ahmed, Timothy D. Jones, Francis J. Carr, James P. Gregson
  • Dress-shaped organizer
    Patent number: D699468
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: February 18, 2014
    Assignee: Umbra, LLC
    Inventor: Matthew J. Carr
  • Dress-shaped organizer
    Patent number: D699964
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: February 25, 2014
    Assignee: Umbra LLC
    Inventors: Matthew J. Carr, Sung wook Park
  • Dress-shaped organizer
    Patent number: D701705
    Type: Grant
    Filed: July 9, 2013
    Date of Patent: April 1, 2014
    Assignee: Umbra LLC
    Inventors: Matthew J. Carr, Alan Wisniewski
  • Dress-shaped organizer
    Patent number: D701706
    Type: Grant
    Filed: September 11, 2013
    Date of Patent: April 1, 2014
    Assignee: Umbra LLC
    Inventors: Matthew J. Carr, Beth Ann Cott
  • Dress-shaped organizer
    Patent number: D708862
    Type: Grant
    Filed: October 30, 2012
    Date of Patent: July 15, 2014
    Assignee: Umbra LLC
    Inventors: Matthew J. Carr, Alan Wisniewski